An interventional study of Robot-guided echo and Standard echocardiogram in Echocardiography, sponsored by Baker Heart and Diabetes Institute. Not yet recruiting at 1 site in Australia. Per ClinicalTrials.gov, last updated 2024-12-19.
Sponsored by Baker Heart and Diabetes Institute · Not applicable, Interventional, and Diagnostic
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Echocardiography is a cornerstone of modern cardiology management, but access in rural and remote areas is limited. We have developed a robot ("Edler" named after the originator of echocardiography) which enables a sonographer to complete an examination at a distance. This study seeks to compare the images obtained by both methods, the completeness of the exam over a feasible time, and to identify particular components of the exam that are difficult to obtain using the robot.
The EAGER study is an effectiveness and feasibility trial of robot -assisted echo.
Patients who have undergone a standard echo will be asked to have a repeat study with a different sonographer, working remotely, obtaining images using the robot. This study is limited to 1 hour and as many views as possible will be obtained. During the study, the remote sonographer and patient are in direct contact over a video link. Another person will be in the room with the patient and the patient will be instructed on the use of a stop switch which will disengage the robot if they feel uncomfortable.
The acquired images will be saved to the imaging cloud and interpreted by an imaging specialist blinded to the original echocardiogram. A side-by-side comparison will be undertaken for each view, and image quality and study completeness will be assessed.
Baker Heart and Diabetes Institute is the lead sponsor of 26 studies on the registry; 8 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Standard echo exam provided by a sonographer using a standard view template
Diagnostic Test: Standard echocardiogram
Robotic echo exam provided by a sonographer using a standard view template
Diagnostic Test: Robot-guided echo
This echo will be performed by a remote sonographer, though a robot
Echocardiogram acquired by a sonographer at the patient's bedside
Proportion complete
Proportion of a standard acquisition protocol obtainable using robotic acquisition over 1 hour
Time frame: 1 hour
Proportion complete
Proportion of echo views with the same information provided by conventional echo
Time frame: 1 hour
Proportion diagnostic features correctly identified by robotic echo
Proportion diagnostic features correctly identified by robotic echo
Time frame: 1 hour
Plan to share: Yes — De-identified individual participant data that underlie the results reported in this project (text, tables, figures and appendices) will be made available.
Supporting information: Study protocol
Time frame: Dates - material will be made available immediately following publication, with no end date.
Access criteria: The authors are pleased to collaborate with other researchers who provide a methodologically sound proposal, to achieve the aims of the approved proposal, including individual participant data meta-analysis. Proposals should be directed to tom.marwick@baker.edu.au. To gain access, data requestors will need to sign a data access agreement.
Data sharing details ↗ · www.baker.edu.au
No publications or documents are linked to this record.
Start is estimated for Jan 2025; primary completion for Dec 2025, 10 months later.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in Dec 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Baker Heart and Diabetes Institute